Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

MarketScanners

View as an RSS Feed
View MarketScanners' Comments BY TICKER:
Latest  |  Highest rated
  • Latest Research Suggests Amarin Value Now Higher As It Awaits FDA Approval [View article]
    Again, for those of you who have not read this (including the somewhat misinformed author of this article):

    More info here: http://bit.ly/ICQcUI

    Omthera Pharmaceuticals (Private, Not Rated) disclosed Phase 3 top-line results for Epanova

    l Epanova is a ultra-pure mixture of free fatty acids EPA and DHA

    l AMR101 is a omega-3 fatty acid, comprising ~96% ultra-pure EPA

    l Both are lipid-lowering drugs, targeting the large hypertriglyceridemia market

    l AMR101’s main advantage is that it does not raise LDL (bad cholesterol)

    l Omthera did not disclose LDL data, which prompted speculation that the drug might raise LDL

    l Krill oil based CaPre® not only seems to decrease triglycerides, but also appears to reduce LDL and to increase HDL (good cholesterol)
    Apr 30 05:50 PM | 1 Like Like |Link to Comment
  • Solid Fundamental Bet: Shares Of Marine Omega-3 Phospholipids Leader Ready Climb [View article]
    Is it any wonder Garza has thousands of followers and the naysayers have two?

    As an analyst/reporter the man is right FAR more often than he is wrong and when it comes to NEPT. He is 1000% right.

    Some new reading materials for those who missed the HUGE run-up this week. Get a clue:

    http://slidesha.re/ICQcUI

    http://slidesha.re/JvPAOB
    Apr 27 06:54 AM | 0 Likes Like |Link to Comment
COMMENTS STATS
2 Comments
1 Like